ctDNA · cfDNA · Validated NGS panels

Liquid Biopsy

Industry-leading validated panels and custom solutions for cancer liquid biopsy — supporting clinical trials, retrospective studies, and method comparisons.

What is a liquid biopsy?

Tumor insight from a blood draw

A liquid biopsy captures and analyzes circulating nucleic acids and proteins in biological fluids — free-floating, like cell-free DNA (cfDNA), or carried in exosomes and circulating tumor cells.

Liquid biopsy tests support early cancer detection and treatment response monitoring when tumor tissue is insufficient or unavailable, or when a non-invasive option is needed.

CtDNA in circulation

Our validated panels

Run industry-leading panels, or your own

Our team can run every panel below, or any custom panel.

Illumina

TruSight Oncology 500 ctDNA

SNVs, indels, CNVs, and fusions across 523 genes, plus tumor mutational burden (TMB) and microsatellite instability (MSI).

Illumina

TruSight Tumor 170

DNA and RNA variants from the same FFPE sample.

Comprehensive support

Beyond the panel

icon project management

Study support

  • Clinical trials
  • Retrospective studies
  • Method comparisons
  • Minimal residual disease (MRD) monitoring
  • Bioinformatics for every study type
icon magnify glass

Additional analyses

  • miRNA-seq and RNA-seq
  • qPCR expression analysis
  • Whole genome, exome, and transcriptome sequencing
  • Custom panel development

Don’t see what you need?

Pre-analytical handling matters for ctDNA. We can advise on collection, processing, and custom panels for your study.

Bring liquid biopsy into your program.

Tell us about your indication, sample type, and study design.